We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+7.14%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$679M
AUM Growth
+$35.2M
Cap. Flow
+$16.7M
Cap. Flow %
2.46%
Top 10 Hldgs %
37.13%
Holding
123
New
38
Increased
24
Reduced
14
Closed
25

Top Buys

Rank Stock Value
1
HCC icon
Warrior Met Coal
HCC
+$16.6M
2
AABA
Altaba Inc
AABA
+$16.3M
3
FOGO
Fogo de Chao, Inc. Common Stock
FOGO
+$11.1M
4
ADNT icon
Adient
ADNT
+$11.1M
5
BTU icon
Peabody Energy
BTU
+$9.55M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$50.4M
2
HLF icon
Herbalife
HLF
+$11.6M
3
CC icon
Chemours
CC
+$10.7M
4
ONDK
On Deck Capital, Inc.
ONDK
+$6.3M
5
WRLD icon
World Acceptance Corp
WRLD
+$5.18M

Sector Composition

Rank Sector Weight
1 Financials 13.55%
2 Healthcare 12.2%
3 Consumer Discretionary 11.52%
4 Real Estate 5.96%
5 Industrials 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAPN
51
PUT
Happen Inc
HAPN
$2.08B
$3.86M 0.57%
140,000
– –
IBM icon
52
PUT
IBM
IBM
$202B
$3.85M 0.57%
+26,150
New +$3.94M
INNL
53
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$3.81M 0.56%
+1,669,679
New +$3.56M
DRRX
54
DELISTED
DURECT Corp
DRRX
$3.34M 0.49%
214,000
-8,500
-4% -$96.8K
GLMD icon
55
Galmed Pharmaceuticals
GLMD
$3.94M
$3.1M 0.46%
2,778
– –
AGRO icon
56
Adecoagro
AGRO
$1.53B
$3M 0.44%
300,000
– –
IMMU
57
DELISTED
Immunomedics Inc
IMMU
$2.87M 0.42%
325,000
-500,000
-61% -$3.51M
APRN
58
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$2.75M 0.41%
+1,637
New +$2.85M
ERII icon
59
Energy Recovery
ERII
$434M
$2.7M 0.4%
325,200
+75,200
+30% +$602K
DRNA
60
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.54M 0.37%
800,000
– –
ORCL icon
61
PUT
Oracle
ORCL
$331B
$2.51M 0.37%
50,000
-50,000
-50% -$2.28M
ALDX icon
62
Aldeyra Therapeutics
ALDX
$91.7M
$2.44M 0.36%
+525,093
New +$2.41M
FATE icon
63
Fate Therapeutics
FATE
$281M
$1.91M 0.28%
588,237
+118,237
+25% +$453K
WU icon
64
PUT
Western Union
WU
$2.57B
$1.91M 0.28%
100,000
– –
CLACW
65
DELISTED
Capitol Acquisition Corp. III Warrants
CLACW
$1.87M 0.28%
850,000
+350,000
+70% +$599K
JPM icon
66
JPMorgan Chase
JPM
$939B
$1.83M 0.27%
20,000
– –
CNACU
67
DELISTED
Constellation Alpha Capital Corp. Unit
CNACU
$1.82M 0.27%
+180,000
New +$1.81M
PLXP
68
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$1.79M 0.26%
+290,909
New +$2.13M
DSX icon
69
Diana Shipping
DSX
$280M
$1.78M 0.26%
+627,003
New +$1.82M
PAAS icon
70
Pan American Silver
PAAS
$18.6B
$1.68M 0.25%
100,000
– –
INSEW
71
DELISTED
Inspired Entertainment, Inc. Warrants
INSEW
$1.56M 0.23%
1,311,448
– –
BKD icon
72
Brookdale Senior Living
BKD
$3.62B
$1.54M 0.23%
105,000
– –
TDW icon
73
Tidewater
TDW
$3.91B
$1.3M 0.19%
+55,850
New +$1.5M
ACHN
74
DELISTED
Achillion Pharmaceuticals
ACHN
$1.15M 0.17%
250,000
+50,000
+25% +$201K
ADVM
75
DELISTED
Adverum Biotechnologies
ADVM
$1.06M 0.16%
42,500
+7,500
+21% +$205K
1 2
3
4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, 683 Capital Management held 123 positions worth $679M, up 5.5% from $644M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

683 Capital Management's Q2 2017 filing shows 38 new, 24 increased, 14 reduced and 25 closed positions. Its largest new stake was Warrior Met Coal: 957,200 shares worth $16.4M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $50.4M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • 683 Capital Management's largest Q2 2017 buy was Warrior Met Coal: 957,200 shares worth $16.4M.
  • 683 Capital Management added most to Adient in Q2 2017, an estimated $11.1M increase.
  • 683 Capital Management's biggest Q2 2017 reduction was Chemours, cutting an estimated $10.7M.
  • 683 Capital Management fully exited iShares MSCI Emerging Markets ETF in Q2 2017, selling an estimated $50.4M.
  • 683 Capital Management's ten largest holdings make up 37% of its $679M portfolio in Q2 2017.
  • 683 Capital Management opened 38 new positions and closed 25 in Q2 2017.
  • 683 Capital Management's portfolio value rose 5.5% quarter-over-quarter to $679M.

Based on 683 Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.